- Correction
- Open access
- Published:
Correction to: Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
BMC Cancer volume 19, Article number: 378 (2019)
Correction to: Raihan et al. BMC Cancer (2019) 19:315.
https://doi.org/10.1186/s12885-019-5516-5
Following publication of the original article [1], it was reported that the last sentence of the Conclusion section was incorrect. The sentence should read as follows:
“However, further experimental studies need to be carry out in vitro and in vivo to decipher the molecular mechanism underlaying tumour cytolysis and cytokines released due to NDV infection”.
The original article [1] has been corrected. The publishers apologise for any inconvenience caused.
Reference
Raihan et al. BMC Cancer (2019) 19:315. Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines. https://doi.org/https://doi.org/10.1186/s12885-019-5516-5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Raihan, J., Ahmad, U., Yong, Y.K. et al. Correction to: Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines. BMC Cancer 19, 378 (2019). https://doi.org/10.1186/s12885-019-5588-2
Published:
DOI: https://doi.org/10.1186/s12885-019-5588-2